Alicia Roldán Pérez

Universidad Europea de Madrid SLU

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (4)

José-Ángel Hernández-Rivas

SPAIN

View details

Rebeca Rodríguez-Veiga

Instituto de Investigación Sanitaria La Fe

SPAIN

View details

Miguel Sanz

Full Professor - Honorary Professor

University of Valencia

SPAIN

View details

Lucia Lopez Corral

Universidad de Salamanca

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alicia Roldán Pérez

Research Interests

Explore related searches

Contact this professor

Articles (10)

Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy

One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients

Impact of the Current Treatments on the Survival of Patients with Mantle Cell Lymphoma (MCL): A Real-Life Study on Behalf of the Spanish Group of Lymphoma (GELTAMO)

The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians – Poster Session (P001-P708)

AML-391 WHO and ICC 2022 Cytogenetic Abnormalities Defining Acute Myelogenous Leukemia (AML) Myelodysplasia-Related in First-Line Decitabine in Unfit AML Patients

POSTER: AML-391 WHO and ICC 2022 Cytogenetic Abnormalities Defining Acute Myelogenous Leukemia (AML) Myelodysplasia-Related in First-Line Decitabine in Unfit AML Patients

Clinical outcomes after CPX‐351 in patients with high‐risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry

Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry

Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients

Real‐life experience of venetoclax and hypomethylating agents in acute myeloid leukemia patients not candidates for intensive chemotherapy or who are refractory/relapsed: A single‐centre experience

Collaborators (4)

José-Ángel Hernández-Rivas

Rebeca Rodríguez-Veiga

Miguel Sanz

Lucia Lopez Corral

Make your next move.